Arbutus Biopharma Corpora...

NASDAQ: ABUS · Real-Time Price · USD
3.32
-0.05 (-1.48%)
At close: Aug 15, 2025, 3:46 PM

Arbutus Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
6.17M 18.14M 39.02M 10.99M
Cost of Revenue
1.38M 73.7M 1.43M 1.75M
Gross Profit
4.79M -55.56M 37.59M 9.23M
Operating Income
-76.32M -78.1M -65.46M -73.52M
Interest Income
6.58M 5.69M 2.19M 127K
Pretax Income
-69.92M -72.85M -65.01M -76.25M
Net Income
-69.92M -72.85M -69.46M -77.35M
Selling & General & Admin
22.11M 22.48M 17.83M 17.14M
Research & Development
54.04M 73.7M 84.41M 65.5M
Other Expenses
6.34M n/a 2.23M 1.87M
Operating Expenses
82.49M 96.24M 102.24M 82.64M
Interest Expense
137K 459K 1.73M 2.86M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
82.49M 96.24M 102.24M 82.64M
Income Tax Expense
n/a n/a 4.44M 1.1M
Shares Outstanding (Basic)
185.61M 165.96M 150.94M 106.24M
Shares Outstanding (Diluted)
185.61M 165.96M 150.94M 106.24M
EPS (Basic)
-0.38 -0.44 -0.46 -0.73
EPS (Diluted)
-0.38 -0.44 -0.46 -0.73
EBITDA
-68.4M -70.99M -61.86M -71.64M
EBIT
-69.78M -72.39M -63.29M -73.39M
Depreciation & Amortization
1.38M 1.4M 1.43M 1.75M